Intravenous Treatment of Anemia in Pregnancy
Intravenous Treatment of Anemia in Pregnancy
The investigators assess and compare the efficacy of anemia treatment in pregnant women with
 anemia of chronic disease with true iron deficiency and in women with iron deficiency anemia.
Fifty anemic pregnant women with moderate anemia were prospectively observed and treated in
 the Anemia clinic at the Department of Obstetrics, University Hospital Zurich. All patients
 had singleton pregnancies. All pregnant women fulfilled criteria of moderate iron deficiency
 anemia defined as hemoglobin (Hb) between 8.0 and 9.9 g/dl and serum ferritin <15 μg/l. In
 all women, the analyses of a blood count, iron status, erythropoietin, cross reactive protein
 (CRP), folic acid and vitamin B12 were conducted. According to hemoglobin level at the start
 of the therapy, the women were either treated with intravenous iron and rhEPO or with
 intravenous iron only twice weekly. Patients with an Hb level between 9.0 and 9.9 g/dl (33
 patients) received 200 mg iron sucrose (VENOFER®, Vifor Int., St. Gallen, Switzerland)
 intravenously twice weekly (group A). If response to therapy was poor (i.e. Hb increase <0.7
 g/dl) after 2 weeks (13 patients), patients additionally received rhEPO (10,000 U EPREX®,
 Janssen-Cilag, Baar, Switzerland) (group B). This cut-off for adequate primary response the
 investigators choose on the basis of previous experience. Patients with an Hb between 8.0 and
 8.9 g/dl (17 patients) received iron sucrose (Venofer) and rhEPO (Eprex) twice weekly from
 the start of therapy (group C).

 Sufficient overall response to therapy (the difference of baseline hemoglobin and after
 therapy) was defined as Hb increase >1.0 g/dl. The maximum total iron dose was 1,600 mg,
 therefore therapy was stopped if the maximal iron sucrose dose was administered, or target Hb
 > 10.5 g/dL was achieved.
Inclusion Criteria:

 -  pregnant women with hemoglobin between 8.0 and 9.9 g/dl and serum ferritin <15 μg/l

 Exclusion Criteria:

 -  vitamin B12 deficiency anemia

 -  folic acid deficiency anemia

 -  hemoglobinopathy

 -  multiples

 -  liver disease

 -  kidney disease